. “With invivodata’s ePRO solution, our customers get the benefit of combining science and technology in a Web-based PRO data collection method,” said Alex O’Toole, Vice President of Clinical Strategic Alliances, Quintiles.
Pittsburgh, PA (PRWEB) June 15, 2011
invivodata inc.®, the industry leader in patient reported outcomes (PRO) solutions and services for global clinical research, today announced the availability of DiaryPRO® Web, its Web-based electronic PRO (ePRO) data collection solution. An extension of invivodata’s handheld ePRO solution (DiaryPRO® 170 Smartphone), DiaryPRO Web provides all of the scientific design and ease-of-use features necessary for capturing valid, reliable patient data in a Web interface.
DiaryPRO Web’s easy-to-use patient interface and electronic assessment capabilities, combined with the ability to run on any personal computer with a Web browser, gives it the power and flexibility to deliver quality data and increased study efficiencies without deploying devices to all patients.
“DiaryPRO Web shares many of the same design and service elements that have been used in hundreds of DiaryPRO handheld trials to date, including integration with EPX™, our ePRO management system”, said Doug Engfer, President and CEO of invivodata. “We designed DiaryPRO Web primarily to meet the needs of clinical trial sponsors conducting late stage and post-marketing research, where hundreds or thousands of patients are required to collect the safety or efficacy data necessary for post-approval analysis.”
Because the considerations for using a Web-based ePRO solution are different than those using a handheld ePRO solution, invivodata offers scientific and regulatory support to clinical researchers as they make critical decisions about their ePRO modality options.
“We are pleased to offer researchers this additional, reliable ePRO choice and to provide our experience and knowledge of ePRO best practices to help them identify which solution is best suited for their clinical objectives,” said Dr. Jean Paty, Chief Scientist and Regulatory Advisor with invivodata’s consulting division, PRO Consulting®. “While DiaryPRO Web offers a very flexible option for capturing important PRO data, researchers should understand and consider the differences in the scientific and regulatory requirements for its use in clinical research.”
“Quintiles is committed to turning quality data into knowledge and to delivering the best ePRO strategy and modality that enhances service delivery to our customers,” said Alex O’Toole, Vice President of Clinical Strategic Alliances, Quintiles. “With invivodata’s ePRO solution, our customers get the benefit of combining science and technology in a Web-based PRO data collection method.”
invivodata representatives will be offering demonstrations of DiaryPRO Web at booth #1508 during the DIA Annual meeting, June 19-22 in Chicago, IL. Additional information on DiaryPRO Web and invivodata’s other proven ePRO solutions can be found at http://www.invivodata.com/solutions.
invivodata is the only fully-integrated PRO Solutions Organization delivering regulatory-proven strategic consulting and practical ePRO solutions to biopharmaceutical companies who depend upon patient-centered research. From crafting PRO measurement strategy to collecting PRO data electronically, invivodata helps its customers strategically use patient reported data to support labeling claims, enhance market access, and meet other clinical program objectives. Through partnerships with leading CROs and eClinical technology providers, invivodata seamlessly integrates into the clinical trial ecosystem, helping to minimize operational risk and maximize efficiencies. invivodata’s solutions have been used in over 350 clinical programs and are built upon the industry-leading ePRO system in delivering primary efficacy data for global drug approvals. invivodata inc. is a privately held company with global headquarters in Pittsburgh, PA., USA; its European headquarters is in London, England; and its technology development center is in Scotts Valley, CA., USA. For more information, visit http:http://www.invivodata.com